Alnylam Pharmaceuticals
ALNY
#661
Rank
โ‚ฌ28.84 B
Marketcap
223,62ย โ‚ฌ
Share price
-8.51%
Change (1 day)
43.10%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company